EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Safety and efficacy of pharmacological inhibition of ketohexokinase in hereditary fructose intolerance

Evi Jc Koene, Amée M Buziau, David Cassiman, Timothy M Cox, Judith Bons, Jean Ljm Scheijen, Casper G Schalkwijk, Steven Jr Meex, Aditi R Saxena, William P Esler, Vera B Schrauwen-Hinderling, Patrick Schrauwen und 1 weitere

Journal of Clinical Investigation · 17.03.2025 · 135 (6)

DOI: 10.1172/jci187376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 11.02.2025. Verfasst von Evi Jc Koene und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Movement Sciences and. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

sponsorship: Pfizer inc.|8503244430/1400

Schlagwörter

Stichwörter der Autor:innen

Carbohydrate metabolismClinical trialsDrug therapyEndocrinologyGenetic diseasesMetabolism

Autor:innen und Institutionen

  • Department of Nutrition and Movement Sciences and.
  • Institute of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, Netherlands.
  • Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, Netherlands.
  • Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands.
  • Department Chrometa, KU Leuven, Leuven, Belgium.
  • Department of Gastroenterology-Hepatology and Metabolic Centre, University Hospitals Leuven, Leuven, Belgium.

Förderung

  • Pfizer inc.

Zitieren

APA

Koene, E. J., Buziau, A. M., Cassiman, D., Cox, T. M., Bons, J., Scheijen, J. L., Schalkwijk, C. G., Meex, S. J., Saxena, A. R., Esler, W. P., Schrauwen-Hinderling, V. B., Schrauwen, P., & Brouwers, M. C. (2025). Safety and efficacy of pharmacological inhibition of ketohexokinase in hereditary fructose intolerance. Journal of Clinical Investigation, 135(6). https://doi.org/10.1172/jci187376

Vancouver

Koene EJ, Buziau AM, Cassiman D, Cox TM, Bons J, Scheijen JL, et al. Safety and efficacy of pharmacological inhibition of ketohexokinase in hereditary fructose intolerance. Journal of Clinical Investigation. 2025;135(6). doi:10.1172/jci187376

BibTeX
@article{Koene2025,
  author = {Koene, Evi Jc and Buziau, Amée M and Cassiman, David and Cox, Timothy M and Bons, Judith and Scheijen, Jean Ljm and Schalkwijk, Casper G and Meex, Steven Jr and Saxena, Aditi R and Esler, William P and Schrauwen-Hinderling, Vera B and Schrauwen, Patrick and Brouwers, Martijn Cgj},
  title = {Safety and efficacy of pharmacological inhibition of ketohexokinase in hereditary fructose intolerance},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {6},
  doi = {10.1172/jci187376}
}
Kostenlos starten →